12 June 2021 | Saturday | News
Image Source : Public Domain
By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab automation workflows and leading global customer channel, we will enhance the value we bring to our biopharma and healthcare customers," said Michael Stubblefield, President and CEO of Avantor. "We're also excited about welcoming the Ritter associates to the Avantor team and building on the connections we already share, including a strong culture of innovation and excellence, as well as a clear commitment to sustainability."
Headquartered in Schwabmünchen, Germany, Ritter is the fastest growing manufacturer of high-quality robotic and liquid handling consumables, including conductive pipette tips engineered to exacting standards. These mission-critical consumables are used in a variety of molecular screening and diagnostic applications, including real-time polymerase chain reaction (PCR), non-molecular assays such as immunoassays, emerging high throughput in vitro diagnostics (IVD) technologies including next generation sequencing, and as part of drug discovery and clinical trial testing in pharma and biotech applications.
The completion of the acquisition follows the receipt of all applicable regulatory approvals.